Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA101 in idiopathic pulmonary fibrosis with refractory chronic cough
NL-OMON41901Active, not recruiting
- Sponsor
- Patara Pharma
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of RVT-1601 in refractory chronic cough (RCC) and idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Patara Pharma. Started Jan 2015; status: active, not recruiting.
02
Drugs
RVT-1601
03
Conditions
refractory chronic cough (RCC)idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NL-OMON41901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41901.